Table 1 HNSCC patient characteristics by tumor site
Oral cavity N = 310 | Oropharynx N = 82 | Larynx N = 124 | ||||
|---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Gender | ||||||
Male | 206 | 66.5 | 69 | 84.1 | 101 | 81.5 |
Female | 104 | 33.5 | 13 | 15.9 | 23 | 18.5 |
Race | ||||||
White | 266 | 85.8 | 76 | 92.7 | 99 | 79.8 |
Black or African American | 20 | 6.5 | 6 | 7.3 | 19 | 15.3 |
Asian | 10 | 3.2 | 0 | 0 | 1 | 0.8 |
American Indian or Alaska Native | 1 | 0.3 | 0 | 0 | 1 | 0.8 |
Information not available | 13 | 4.2 | 0 | 0 | 4 | 3.2 |
Ethnicity | ||||||
Hispanic/Latino | 16 | 5.2 | 3 | 3.7 | 5 | 4 |
Non-Hispanic/Latino | 269 | 86.8 | 76 | 92.7 | 109 | 87.9 |
Information not available | 25 | 8.1 | 3 | 3.7 | 10 | 8.1 |
Smoking | ||||||
Ever smoker | 215 | 69.4 | 56 | 68.3 | 113 | 91.1 |
Lifelong non-smoker | 86 | 27.7 | 25 | 30.5 | 8 | 6.5 |
Information not available | 9 | 2.9 | 1 | 1.2 | 3 | 2.4 |
HPV status | ||||||
HPV + | 31 | 10 | 56 | 68.3 | 11 | 8.9 |
HPV − | 278 | 89.7 | 26 | 31.7 | 112 | 90.3 |
Indeterminate | 1 | 0.3 | 0 | 0 | 1 | 0.8 |
Vital status | ||||||
Alive | 197 | 63.5 | 69 | 84.1 | 82 | 66.1 |
Deceased | 113 | 36.5 | 13 | 15.9 | 42 | 33.9 |
Nodal status | ||||||
Positive | 147 | 47.4 | 34 | 41.5 | 58 | 46.8 |
Negative | 119 | 38.4 | 16 | 19.5 | 42 | 33.9 |
Information not available | 44 | 14.2 | 32 | 39 | 24 | 19.4 |
Pathologic tumor stage | ||||||
Stage I | 19 | 6.1 | 4 | 4.9 | 2 | 1.6 |
Stage II | 56 | 18.1 | 10 | 12.2 | 12 | 9.7 |
Stage III | 52 | 16.8 | 9 | 11.0 | 14 | 11.3 |
Stage IV | 160 | 51.6 | 28 | 34.1 | 79 | 63.7 |
Information not available | 23 | 7.4 | 31 | 37.8 | 17 | 13.7 |